Differential expression of protein kinase C isoforms in streptozotocin- induced diabetic rats

Kidney International

Volumn 56, Issue 5, 1999, Pages 1737-1750

  Kang, Ningling ^a,b   Alexander, Gabriele ^a,b   Park, Joon Keun ^a,b   Maasch, Christian ^a,b   Buchwalow, Igor ^a,b   Luft, Friedrich C ^a,b   Haller, Hermann ^a,b,c  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

^c FRANZ VOLHARD CLINIC   (Germany)

Author keywords

Antisense oligonucleotides; Diabetes; Endothelium; Gene transfer; Hyperglycemia; Kidney; PKC isoform

Indexed keywords

ISOENZYME; PROTEIN KINASE C; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; ENZYME LOCALIZATION; HYPERGLYCEMIA; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TISSUE DISTRIBUTION;

EID: 0032704786     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00725.x     Document Type: Article

References (69)

1. 1. CAMMARATA PR, FAN W, JIN Y, YORIO T: Protein kinase C activity and its relationship to myo-inositol uptake during hyperglycemic conditions in cultured bovine lens epithelial cells. Curr Eye Res 12:403-412, 1993
2. 2. DERUBERTIS FR, CRAVEN PA: Activation of protein kinase C in glomerular cells in diabetes: Mechanisms and potential links to the pathogenesis of diabetic glomerulopathy. Diabetes 43:1-8, 1994
3. 3. GREENE DA, LATTIMER SA: Biochemical alterations and complications in diabetes. Clin Chem 32:B42-B47, 1986
4. 4. HALLER H, DRAB M, LUTT FC: The role of hyperglycemia and hyperinsulinemia in the pathogenesis of diabetic angiopathy. Clin Nephrol 46:246-255, 1996
5. 5. ZIYADEH FN: Mediators of hyperglycemia and the pathogenesis of matrix accumulation in diabetic renal disease. Miner Electrolyte Metab 21:292-302, 1995
6. 6. CRAVEN PA, STUDER RK, NEGRETE H, DERUBERTIS FR: Protein kinase C in diabetic nephropathy. J Diabetes Compl 9:241-245, 1995
7. 7. AYO SH, RADNIK R, GARONI JA, TROYER DA, KREISBERG, JI: High glucose increases diacylglycerol mass and activates protein kinase C in mesangial cell cultures. Am J Physiol 261:F571-F577, 1991
8. 8. CHIARUGI V, BRUNI P, PASQUALI F, MAGNELLI L, BASI G, RUGGIERO M, FARNARARO M: Synthesis of diacylglycerol de novo is responsible for permanent activation and down-regulation of protein kinase C in transformed cells. Biochem Biophys Res Commun 164:816-823, 1989
9. 9. CRAVEN PA, DAVIDSON CM, DERUBERTIS FR: Increase in diacylglycerol mass in isolated glomeruli by glucose from de novo synthesis of glycerolipids. Diabetes 39:667-674, 1990
10. 10. FARESE RV, ROSIC N, STANDAERT M, BABISCHKIN J, COOPER DR, DAVIS JS, POLLET RJ: Further evidence implicating diacylglycerol generation and protein kinase C activation in agonist-induced increases in glucose uptake: Insulin-like effects of phenylephrine in BC3H-1 myocytes. Diabetes 35:951-957, 1986
11. 11. ISHIZUKA T, HOFFMAN J, COOPER DR, WATSON JE, PUSHKIN DB, FARESE RV: Glucose-induced synthesis of diacylglycerol de novo is associated with translocation (activation) of protein kinase C in rat adipocytes. FEBS Lett 249:234-238, 1989
12. 12. OKUMURA K, AKIYAMA N, HASHIMOTO H, OGAWA K, SATAKE T: Alteration of 1,2-diacylglycerol content in myocardium from diabetic rats. Diabetes 37:1168-1172, 1988
13. 13. WOLF BA, WILLIAMSON JR, EASOM RA, CHANG K, SHERMAN WR, TURK J: Diacylglycerol accumulation and microvascular abnormalities induced by elevated glucose levels. J Clin Invest 87:31-38, 1991
14. 14. CRAVEN PA, DERUBERTIS FR: Protein kinase C is activated in glomeruli from streptozotocin diabetic rats: Possible mediation by glucose. J Clin Invest 83:1667-1675, 1989
15. 15. GARCIA PARAMIO P, CARMENA MJ, GUTIERREZ OCANA MT, RECIO MN, PRIETO JC: Alteration of protein kinase C activity in diabetic rat prostate. Biochem Biophys Rev Commun 195:166-172, 1993
16. 16. HALLER H, BAUR E, QUASS P, BEHREND M, LINDSCHAU C, DISTLER A, LUFT FC: High glucose concentrations and protein kinase C isoforms in vascular smooth muscle cells. Kidney Int 47:1057-1067, 1995
17. 17. ISHH H, KOYA D, KING GL: Protein kinase C activation and its role in the development of vascular complications in diabetes mellitus. J Mol Med 76:21-31, 1998
18. 18. KUNISAKI M, BURSELL SE, UMEDA F, NAWATA H, KING GL: Normalization of diacylglycerol-protein kinase C activation by vitamin E in aorta of diabetic rats and cultured rat smooth muscle cells exposed to elevated glucose levels. Diabetes 43:1372-1377, 1994
19. 19. KUNISAKI M, BURSELL SE, UMEDA F, NAWATA H, KING GL: Prevention of diabetes-induced abnormal retinal blood flow by treatment with d-alpha-tocopherol. Biofactors 7:55-67, 1998
20. 20. SHIBA T, INOGUCHI T, SPORTSMAN JR, HEATH WF, BURSELL S, KING GL: Correlation of diacylglycerol level and protein kinase C activity in rat retina to retinal circulation. Am J Physiol 265:E783-E793, 1993
21. 21. STUDER RK, CRAVEN PA, DERUBERTIS FR: Role for protein kinase C in the mediation of increased fibronectin accumulation by mesangial cells grown in high-glucose medium. Diabetes 42:118-126, 1993
22. 22. TANAKA Y, KASHIWAGI A, OGAWA T, ABE N, ASAHINA T, IKEBUCHI M, TAKAGI Y, SHIGETA Y: Effect of verapamil on cardiac protein kinase C activity in diabetic rats. Eur J Pharmacol 200:353-356, 1991
23. 23. WILLIAMS B, SCHRIER RW: Glucose-induced protein kinase C activity regulates arachidonic acid release and eicosanoid production by cultured glomerular mesangial cells. J Clin Invest 92:2889-2896, 1993
24. 24. WILLIAMS B, TSAI P, SCHRIER RW: Glucose-induced downregulation of angiotensin II and arginine vasopressin receptors in cultured rat aortic vascular smooth muscle cells: Role of protein kinase C. J Clin Invest 90:1992-1999, 1992
25. + antiport activity and gene expression in cultured vascular smooth muscle cells: Role of protein kinase C. J Clin Invest 93:2623-2631, 1994
26. 26. XIA P, INOGUCHI T, KERN TS, ENGERMAN RL, OATES PJ, KING GL: Characterization of the mechanism for the chronic activation of diacylglycerol-protein kinase C pathway in diabetes and hyperpalactosemia. Diabetes 43:1122-1129, 1994
27. 27. ZIYADEH FN, FUMO P, RODENBERGER CH, KUNCIO GS, NIELSON EG: Role of protein kinase C and cyclic AMP/protein kinase A in high glucose-stimulated transcriptional activation of collagen alpha 1 (IV) in glomerular mesangial cells. J Diabetes Compl 9:255-261, 1995
28. 28. KREISBERG JI: Hyperglycemia and microangiopathy: Direct regulation by glucose of microvascular cells. Lab Invest 67:416-426, 1992
29. 29. PFEIFFER A, SCHATZ H: Diabetic microvascular complications and growth factors. Exp Clin Endocrinol Diabetes 103:7-14, 1995
30. 30. WILLIAMS B: Glucose-induced vascular smooth muscle dysfunction: The role of protein kinase C. J Hypertens 13:477-486, 1995
31. 31. CHURCH DJ, BRACONI S, VALLOTTON MB, LANG U: Protein kinase C-mediated phospholipase A2 activation, platelet-activating factor generation and prostacyclin release in spontaneously beating rat cardiomyocytcs. Biochem J 290:477-482, 1993
32. 32. WILLIAMS B, SCHRIER RW: Characterization of glucose-induced in situ protein kinase C activity in cultured vascular smooth muscle cells. Diabetes 41:1464-1472, 1992
33. 33. KUNISAKI M, FUMIO U, NAWATA H, KING GL: Vitamin E normalizes diacylgiycerol-protein kinase C activation induced by hyperglycemia in rat vascular tissues. Diabetes 45(Suppl 3):S117-S119, 1996
34. 34. INOGUCHI T, BATTAN R, HANDLER E, SPORTSMAN JR, HEATH W, KING GL: Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats: Differential reversibility to glycemic control by islet cell transplantation. Proc Natl Acad Sci USA 89:11059-11063, 1992
35. 35. HISE MK, MEHTA PS: Characterization and localization of calcium/phospholipid-dependent protein kinase-C during diabetic renal growth. Endocrinology 123:1553-1558, 1988
36. 36. HALLER H, LINDSCHAU C, QUASS P, DISTLER A, LUFT FC: Differentiation of vascular smooth muscle cells and the regulation of protein kinase C-alpha. Circ Res 76:21-29, 1995
37. 37. HALLER H, LINDSCHAU C, LUFT FC: Role of protein kinase C in intracellular signaling. Ann NY Acad Sci 733:313-324, 1994
38. 38. KOYA D, JIROUSEK MR, LIN YW, ISHII H, KUBOKI K, KING GL: Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats. J Clin Invest 100:115-126, 1997
39. 39. ISHII H, JIROUSEK MR, KOYA D, TAKAGI C, XIA P, CLERMONT A, BURSELL SE, KERN TS, BALLAS LM, HEATH WF, STRAMM LE, FEENER EP, KING GL: Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor. Science 272:728-731, 1996
40. 40. HALLER H, ZIEGLER W, LINDSCHAU C, LUFT FC: Endothelial cell tyrosine kinase receptor and G-protein coupled receptor activation involves distinct protein kinase C isoforms. Arterioscler Thromb Vasc Biol 16:678-686, 1996
41. 41. HEMPEL A, MAASCH C, HEINTZE U, LINDSCHAU C, DIETZ R, LUFT FC, HALLER H: High glucose concentrations increase endothelial cell permeability via activation of protein kinase C alpha. Circ Res 81:363-371, 1997
42. 42. HALLER H, PARK JK, DRAGUN D, LIPPOLDT A, LUFT FC: Leukocyte infiltration and ICAM-1 expression in two-kidney one-clip hypertension. Nephrol Dial Transplant 12:899-903, 1997
43. 43. HALLER H, SMALLWOOD JI, RASMUSSEN H: Protein kinase C translocation and contraction in intact vascular smooth muscle strips. J Biochem 270:375-381, 1989
44. 43. HALLER H, DRAGUN D, MIETHKE A, PARK JK, WIES A, LIPPOLDT A, GROSS V, LUFT FC: Antisense oligonucleotides for ICAM-1 attenuate reperfusion injury and renal failure in the rat. Kidney Int 50:473-480, 1996
45. 44. LINDSHAU C, QUASS P, DRAB M, LUFT FC, HALLER H: Glucose-induced expression of TGF-β and TGF-β receptor in vascular smooth muscle cells is mediated by protein kinase C α. Circ Res (in press)
46. 45. KIKKAWA R, HANEDA M. UZU T, KOYA D, SUGIMOTO T, SHIGETA Y: Translocation of protein kinase C alpha and zeta in rat glomerular mesangial cells cultured under high glucose conditions. Diahetologia 37:838-841, 1994
47. 46. AVIGNON A, STANDAERT ML, YAMADA K, MISCHAK H, SPENCER B, FARESE RV: Insulin increases mRNA levels of protein kinase C-alpha and -beta in rat adipocytes and protein kinase C-alpha-beta and -theta in rat skeletal muscle. Biochem J 308:181-187, 1995
48. 47. BANDYOPADHYAY G, STANDAERT ML, GALLOWAY L, MOSCAI J, FARESE RV: Evidence for involvement of protein kinase C (PKC)-zeta and noninvolvement of diacylglycerol-sensitive PKCs in insulin-stimulated glucose transport in L6 myotubes. Endocrinology 138:4721-4731, 1997
49. 48. STANDAERT ML, GALLOWAY L, KARNAM P, BANDYOPADHYAY G, MOSCAT J, FARESE RV: Protein kinase C-zeta as a downstream effector of phosphatidylinositol 3-kinase during insulin stimulation in rat adipocytes: Potential role in glucose transport. J Biol Chem 272:30075-30082, 1997
50. 49. ZHAO L, STANDAERT ML, COOPER DR, AVIGNON A, FARESE RV: Effects of insulin on protein kinase-C (PKC) in HIRC-B cells: Specific activation of PKC epsilon and its resistance to phorbolester-induced down-regulation. Endocrinology 135:2504-2510, 1994
51. 50. DONNELLY R, REED MJ, AZHAR S, REAVEN GM: Expression of the major isoenzyme of protein kinase-C in skeletal muscle, nPKC theta, varies with muscle type and in response to fructose-induced insulin resistance. Endocrinology 135:2369-2374, 1994
52. 51. GILES TD, OUYANG J, KERUT EK, GIVEN MB, ALLEN GE, MCILWAIN EF, GREENBERG SS: Changes in protein kinase C in early cardiomyopathy and in gracilis muscle in the BB/Wor diabetic rat. Am J Physiol 274:H295-H307, 1998
53. 52. KELLERER M, MUSHACK J, MISCHAK H, HARING HU: Protein kinase C (PKC) epsilon enhances the inhibitory effect of TNF alpha on insulin signaling in HEK293 cells. FEBS Lett 418:119-122, 1997
54. 53. OHNO S, MIZUNO K, ADACHI Y, HATA A, ARHA Y, AKIMOTO K, OSADA S, HIRAI S, SUZUKI K: Activation of novel protein kinases C delta and C epsilon upon mitogenic stimulation of quiescent rat 3Y1 fibroblasts. J Biol Chem 269:17495-17501, 1994
55. 54. SASAGURI T, KOSAKA C, HIRATA M, MASUDA J, SHIMOKADO K, FUJISHIMA M, OGATA J: Protein kinase C-mediated inhibition of vaseular smooth muscle cell proliferation: The isoforms that may mediate G1/S inhibition. Exp Cell Res 208:311-320, 1993
56. 55. TRAUB O, MONIA BP, DEAN NM, BERK BC: PKC-epsilon is required for mechano-sensitive activation of ERK1/2 in endothelial cells. J Biol Chem 272:31251-31257, 1997
57. 56. HUWILER A, STAUDT G, KRAMER RM, PFEILSCHIFTER J: Cross-talk between secretory phospholipase A2 and cytosolic phospholipase A2 in rat renal mesangial celts. Biochim Biophys Acta 1348:257-272, 1997
58. 57. MUELLER HK, FRITSCHE U, HASLINGER A, LANDGRAF R: Glucose-induced fibronectin expression in endothelial cells is mediated by protein kinase C. Exp Clin Endocrinol Diabetes 105:32-38, 1997
59. 58. KOLCH W, HEIDECKER G, KOCHS G, HUMMEL R, VAHIDI H, MISCHAK H, FINKENZELLER G, MARME D, RAPP UR: Protein kinase C alpha activates RAF-1 by direct phosphorylation. Nature 364:249-252, 1993
60. 59. KARIM Z, DIFONTAINE N, PAILLARD M, POGGIOLI J: Protein kinase C isoforms in rat kidney proximal tubule: Acute effect of angiotensin II. An J Physiol 269:C134-C140, 1995
61. 60. DECOY DL, SNAPPER JR, BREYER MD: Anti sense DNA down-regulates proteins kinase C-epsilon and enhances vasopressin-stimulated Na+ absorption in rabbit cortical collecting duct. J Clin Invest 95:2749-2756, 1995
62. 61. QIU Y, PING P, TANG XL, MANCHIKALAPUDI S, RIZVI A, ZHANG J, TAKANO H, WU WJ, TESCHNER S, BOLLI R: Direct evidence that protein kinase C pays an essential role in the development of late preconditioning against myocardial stunning in conscious rabbits and that epsilon is the isoform involved. J Clin Invest 101:2182-2198, 1998
63. 62. PAUL K, BALL NA, DORN G H, WALSH RA: Left ventricular stretch stimulates angiotensin II-mediated phosphatidylinositol hydrolysis and protein kinase C epsilon isoform translocation in adult guinea pig hearts. Circ Res 81:643-650, 1997
64. 63. MALHOTRA A, REICH D, REICH D, NAKOUZI A, SANGHI V, GEENEN DL, BUTTRICK PM: Experimenlal diabetes is associated with functional activation of protein kinase C epsilon and phosphorylation of troponin I in the heart, which are prevented by angiotensin II receptor blockade. Circ Res 81:1027-1033, 1997
65. 64. NAKANISHI H, EXTON JH: Purification and characterization of the zeta isoform of protein kinasc C from bovine kidney. J Biol Chem 267:16347-16354, 1992
66. 65. VALVERDE AM, TERUEL T, LORENZO M, BENITO M: Involvement of Raf-1 kinase and protein kinase C zeta in insulin-like growth factor I-induced brown adipocyte mitogenic signaling cascades: Inhibition by cyclic adenosinc 3′,5′-monopriosphate. Endocrinology 137:3832-3841, 1996
67. 66. SCHONWASSER DC, MARAIS RM, MARSHALL CJ, PARKER PJ: Activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway by conventional, novel, and atypical protein kinase C isotypes. Mol Cell Biol 18:790-798, 1998
68. 67. LIAO DF, MONIA B, DEAN N, BERK BC: Protein kinase C-zeta mediates angiotensin II activation of ERK1/2 in vascular smooth muscle cells. J Biol Chem 272:6146-6150, 1997
69. 68. MILLER BW, BAIER LD, MORRISON AR: Overexpression of protein kinase C-zeta isoform increases cyclooxygenase-2 and indudble nitric oxide synthase. Am J Physiol 273:C130-C136, 1997